(Q43747147)

26 November 2017

Significant augmentation of pro-apoptotic gene therapy by pharmacologic bcl-xl down-regulation in mesothelioma (English)

1 reference

26 November 2017

0 references

1 reference

Mohiuddin I

1

1 reference

26 November 2017

Cao X

2

1 reference

26 November 2017

Fang B

3

1 reference

26 November 2017

Nishizaki M

4

1 reference

26 November 2017

Smythe WR

5

1 reference

26 November 2017

1 August 2001

1 reference

26 November 2017

1 reference

26 November 2017

8

1 reference

26 November 2017

8

1 reference

26 November 2017

547-554

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700332

26 November 2017

0 references

cites work

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

Natural history and staging of malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

Chemotherapy in malignant pleural mesothelioma. A review.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

Etoposide in malignant pleural mesothelioma: two phase II trials of the EORTC Lung Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

Emerging translational therapies for mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

Treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex thymidine kinase gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

The Bcl-2 protein family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

Short chain fatty acids in the human colon

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

Effects of 5-azacytidine and butyrate on differentiation and apoptosis of hepatic cancer cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

bcl-2 and bak may play a pivotal role in sodium butyrate-induced apoptosis in colonic epithelial cells; however overexpression of bcl-2 does not protect against bak-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

Cancer cell sensitization to fas-mediated apoptosis by sodium butyrate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

Clinical pharmacology of sodium butyrate in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

A binary adenoviral vector system for expressing high levels of the proapoptotic gene bax.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

Absence of p53 mutations in malignant mesotheliomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

Effect of simian virus large T antigen expression on cell cycle control and apoptosis in rat pleural mesothelial cells exposed to DNA damaging agents.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

Amphotericin B-induced apoptosis and cytotoxicity is prevented by the Na+, K+, 2Cl(-)-cotransport blocker bumetanide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

Talc induces apoptosis in human malignant mesothelioma cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

Lovastatin induces apoptosis in malignant mesothelioma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

Induction of apoptosis in lung-cancer cells following bcl-xL anti-sense treatment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700332

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700332

1 reference

Dimensions Publication ID

26 November 2017

0 references

1 reference